Labcorp

Labcorp is a leading global life sciences company dedicated to improving health and enhancing lives through innovative diagnostic solutions and comprehensive drug development services.

With a workforce of over 70,000 employees worldwide, Labcorp operates one of the largest clinical laboratory networks, processing more than 600 million tests annually across approximately 100 countries.

Diagnostic Services

Labcorp offers a wide array of diagnostic tests that assist healthcare providers in making informed decisions.

These tests include blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C testing, and health and wellness services.

The company is also a leader in gene-based and esoteric testing, providing services in areas such as:

• Anatomic pathology/oncology
• Cardiovascular disease
• Coagulation
• Diagnostic genetics
• Endocrinology
• Infectious disease
• Women's health
• Pharmacogenetics
• Parentage and donor testing
• Occupational testing services
• Medical drug monitoring services
• Chronic disease programs
• Kidney stone prevention tests

Drug Development Services

Through its Biopharma Laboratory Services segment, Labcorp supports pharmaceutical, biotechnology, medical device, and diagnostic companies in drug development.

In 2023, this division provided support to 84% of the new drugs and therapeutic products approved by the Food and Drug Administration.

Labcorp's expertise spans the entire drug development process, from early-phase clinical trials to commercialization, ensuring that new treatments reach patients efficiently and safely.

Global Presence

Headquartered in Burlington, North Carolina, Labcorp has a significant presence in the United States, operating nearly 2,000 patient service centers and employing over 6,000 in-office phlebotomists.

The company also has operations in over 100 countries, serving a diverse clientele that includes healthcare providers, pharmaceutical companies, and patients worldwide.

Labcorp maintains offices and facilities in various U.S. locations, including:

• Camden, NJ
• Columbus, GA
• Springfield, MA
• Houston, TX
• San Jose, CA
• Tucson, AZ
• Philadelphia, PA
• Pueblo, CO
• Joliet, IL
• Chesapeake, VA
• Renton, WA
• Bensalem, PA
• Seattle, WA
• Racine, WI
• Jackson, MS
• Charlotte, NC
• Winston-Salem, NC
• Phoenix, AZ
• Baltimore, MD

Recent Developments

In 2023, Labcorp completed the spin-off of Fortrea, an independent Contract Research Organization providing Phase I-IV clinical trial management, patient access, and technology solutions to pharmaceutical and biotechnology organizations globally.

Additionally, Labcorp acquired select assets of Invitae, a leading medical genetics company, extending its leadership in genetic testing solutions for oncology and select rare diseases.

Labcorp's commitment to advancing science and technology continues to drive its mission of improving health and enhancing lives, making it a pivotal player in the global healthcare landscape.